Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

sanofi-aventis takes over Plavix license in Japan

March 7, 2006

BioCryst Pharmaceuticals presents new data on BCX-3607

March 2, 2006

Novel antiplatelet agents claimed in recent Daiichi patent

March 1, 2006

Second phase III trial under way for alfimeprase in catheter occlusion

March 1, 2006

Lee's to begin clinical testing of Declotana in China

Feb. 27, 2006

New agents for treating thrombosis and related disorders reported in recent patents

Feb. 23, 2006

Recent Ono patent reports new coagulation factor Xa inhibitors

Feb. 15, 2006

AstraZeneca withdraws Exanta

Feb. 15, 2006

FDA warns on risks of aprotinin

Feb. 15, 2006

Antiplatelet activity of MRS-2500 observed ex vivo and in vivo

Feb. 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...